Imir Metushi, PhD finished his BS in Chemistry from York University (Toronto, Canada) specializing in analytical chemistry. He then went to pursue a Ph.D in Pharmacology at the University of Toronto where he developed an interest in biomarker development for adverse drug reactions (ADRs). He did a one year post doc at the La Jolla Institute for Allergy and Immunology where he worked on the development of immunoassays used to prescreen for drugs that could have an HLA-linked ADR. He has 23 publications in high quality journals and has given several oral presentations in meetings such as: Society of Toxicology and American Association of Clinical Chemists. His interests are in biomarker discovery as well as performing mass spectrometry applications utilized in the toxicology laboratory. He is currently a second year Clinical Chemistry Fellow at UCSD and is member of several professional associations some of which include: SOT, AACC, CACB and AAAAI.